Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224289826> ?p ?o ?g. }
- W4224289826 endingPage "2389" @default.
- W4224289826 startingPage "2376" @default.
- W4224289826 abstract "Proinflammatory cytokines/chemokines are commonly regulated by RNA-binding proteins at posttranscriptional levels. Human Ag R (HuR)/embryonic lethal abnormal vision-like 1 (ELAVL1) is one of the well-characterized RNA-binding proteins that increases the stability of short-lived mRNAs, which encode proinflammatory mediators. HuR employs its nucleocytoplasmic shuttling sequence (HNS) domain, interacting with poly(ADP-ribose) polymerase 1 (PARP1), which accounts for the enhanced poly-ADP-ribosylation and cytoplasmic shuttling of HuR. Also by using its HNS domain, HuR undergoes dimerization/oligomerization, underlying the increased binding of HuR with proinflammatory cytokine/chemokine mRNAs and the disassociation of the miRNA-induced silencing complex from the targets. Therefore, competitively blocking the interactions of HuR with its partners may suppress proinflammatory mediator production. In this study, peptides derived from the sequence of the HuR-HNS domain were synthesized, and their effects on interfering HuR interacting with PARP1 and HuR itself were analyzed. Moreover, cell-penetrating TAT-HuR-HNS3 was delivered into human and mouse cells or administered into mouse lungs with or without exposure of TNF-α or LPS. mRNA levels of proinflammatory mediators as well as neutrophil infiltration were evaluated. We showed that TAT-HuR-HNS3 interrupts HuR-PARP1 interaction and therefore results in a lowered poly-ADP-ribosylation level and decreased cytoplasmic distribution of HuR. TAT-HuR-HNS3 also blocks HuR dimerization and promotes Argonaute 2-based miRNA-induced silencing complex binding to the targets. Moreover, TAT-HuR-HNS3 lowers mRNA stability of proinflammatory mediators in TNF-α-treated epithelial cells and macrophages, and it decreases TNF-α-induced inflammatory responses in lungs of experimental animals. Thus, TAT-HuR-HNS3 is a promising lead peptide for the development of inhibitors to treat inflammation-related diseases." @default.
- W4224289826 created "2022-04-26" @default.
- W4224289826 creator A5014090178 @default.
- W4224289826 creator A5026906414 @default.
- W4224289826 creator A5030348054 @default.
- W4224289826 creator A5054497098 @default.
- W4224289826 creator A5063241635 @default.
- W4224289826 creator A5074317397 @default.
- W4224289826 creator A5075079503 @default.
- W4224289826 creator A5077467093 @default.
- W4224289826 creator A5081243406 @default.
- W4224289826 creator A5082023632 @default.
- W4224289826 date "2022-05-15" @default.
- W4224289826 modified "2023-10-05" @default.
- W4224289826 title "Cell-Penetrating Peptide TAT-HuR-HNS3 Suppresses Proinflammatory Gene Expression via Competitively Blocking Interaction of HuR with Its Partners" @default.
- W4224289826 cites W1251748139 @default.
- W4224289826 cites W1969785724 @default.
- W4224289826 cites W1972936061 @default.
- W4224289826 cites W1973480874 @default.
- W4224289826 cites W1983486105 @default.
- W4224289826 cites W1989804578 @default.
- W4224289826 cites W1994771436 @default.
- W4224289826 cites W1997272400 @default.
- W4224289826 cites W1998989083 @default.
- W4224289826 cites W2001619317 @default.
- W4224289826 cites W2005558505 @default.
- W4224289826 cites W2011087576 @default.
- W4224289826 cites W2013855617 @default.
- W4224289826 cites W2014209078 @default.
- W4224289826 cites W2019563964 @default.
- W4224289826 cites W2020188047 @default.
- W4224289826 cites W2022299887 @default.
- W4224289826 cites W2024145128 @default.
- W4224289826 cites W2024276071 @default.
- W4224289826 cites W2028493513 @default.
- W4224289826 cites W2029706883 @default.
- W4224289826 cites W2030248691 @default.
- W4224289826 cites W2047165246 @default.
- W4224289826 cites W2054630268 @default.
- W4224289826 cites W2059646461 @default.
- W4224289826 cites W2065144272 @default.
- W4224289826 cites W2079335891 @default.
- W4224289826 cites W2083123268 @default.
- W4224289826 cites W2085147968 @default.
- W4224289826 cites W2085505185 @default.
- W4224289826 cites W2090888546 @default.
- W4224289826 cites W2095247701 @default.
- W4224289826 cites W2099029060 @default.
- W4224289826 cites W2099518931 @default.
- W4224289826 cites W2101243726 @default.
- W4224289826 cites W2102482931 @default.
- W4224289826 cites W2102606027 @default.
- W4224289826 cites W2103262726 @default.
- W4224289826 cites W2111685937 @default.
- W4224289826 cites W2111994795 @default.
- W4224289826 cites W2129414453 @default.
- W4224289826 cites W2135070076 @default.
- W4224289826 cites W2146416818 @default.
- W4224289826 cites W2147320595 @default.
- W4224289826 cites W2159922156 @default.
- W4224289826 cites W2162990291 @default.
- W4224289826 cites W2163785571 @default.
- W4224289826 cites W2163994278 @default.
- W4224289826 cites W2165320975 @default.
- W4224289826 cites W2168169655 @default.
- W4224289826 cites W2213723615 @default.
- W4224289826 cites W2230122368 @default.
- W4224289826 cites W2257082043 @default.
- W4224289826 cites W2401436717 @default.
- W4224289826 cites W2440773800 @default.
- W4224289826 cites W2593505005 @default.
- W4224289826 cites W2606669462 @default.
- W4224289826 cites W2612263474 @default.
- W4224289826 cites W2613445794 @default.
- W4224289826 cites W2725733926 @default.
- W4224289826 cites W2748564011 @default.
- W4224289826 cites W2766509651 @default.
- W4224289826 cites W2791321187 @default.
- W4224289826 cites W2900307975 @default.
- W4224289826 cites W2901500625 @default.
- W4224289826 cites W2939398224 @default.
- W4224289826 cites W2980759136 @default.
- W4224289826 cites W3002398598 @default.
- W4224289826 cites W3003578400 @default.
- W4224289826 cites W3005522420 @default.
- W4224289826 cites W3011217685 @default.
- W4224289826 cites W3026323285 @default.
- W4224289826 cites W3037315173 @default.
- W4224289826 cites W3045132330 @default.
- W4224289826 cites W3048474893 @default.
- W4224289826 cites W3106930452 @default.
- W4224289826 cites W3150562000 @default.
- W4224289826 cites W3169558622 @default.
- W4224289826 cites W4244245194 @default.
- W4224289826 cites W994255587 @default.
- W4224289826 doi "https://doi.org/10.4049/jimmunol.2200002" @default.
- W4224289826 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35444028" @default.
- W4224289826 hasPublicationYear "2022" @default.